Search & Filter
News Type
Topic
Disease
Population
2025 NFID Impact Report: Breaking Through the Noise
In 2025, the National Foundation for Infectious Diseases (NFID) remained a steadfast voice for science and evidence-based guidance. As we look back on 2025, the numbers tell a story of resilience, innovation, and support.
Welcome to Immunization in 2026: Why Evidence-Based Policy Matters More Than Ever
NFID Medical Director Robert H. Hopkins, Jr., MD, examines the challenges—and stakes—facing the immunization community in the year ahead.
Top Webinars You Might Have Missed in 2025
From maternal immunization to reducing vaccine hesitancy, NFID webinars provide healthcare professionals with timely information and practical strategies
There’s Still Time: #GetVaccinated to Help #FightFlu
NFID and partners offer resources for National Influenza Vaccination Week, December 1-5, 2025, to raise awareness about the importance annual flu vaccination …
What You Need To Know This Respiratory Season
From antivirals to immunization, here’s what you need to know to help protect yourself and others from flu, COVID-19, RSV, and pneumococcal disease.
Celebrating Resilient Heroes of Public Health
At the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases paid tribute to 3 outstanding public health champions: Anne E. Goldfeld, MD; Rino Rappuoli, PhD; and Patricia N. Whitley-Williams, MD
Staying on Track: Evidence-Based Vaccine Recommendations
Looking for trusted vaccine guidance? Read on for evidence-based immunization recommendations from professional medical groups and trusted NFID partners …
Why We Give Hepatitis B Vaccines to Infants
For nearly 40 years, hepatitis B vaccination has been recommended for US infants to prevent hepatitis B infection, which can lead to liver damage, failure, and cancer